Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry

Abstract

Patients with VEXAS syndrome required high-dose glucocorticoids to reduce disease activity, and complications-such as malignancy, thrombosis, and infection-occurred frequently within a short observation period.